Tumor-specific intravenous gene delivery using oncolytic adenoviruses.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 19, doi. 10.1038/sj.cgt.7700730
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2005 AND VI 12 AND IP 1
Results: 12
1
2
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 12, doi. 10.1038/sj.cgt.7700746
- By:
- Publication type:
- Article
3
Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 26, doi. 10.1038/sj.cgt.7700754
- By:
- Publication type:
- Article
4
Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 1, doi. 10.1038/sj.cgt.7700755
- By:
- Publication type:
- Article
5
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 46, doi. 10.1038/sj.cgt.7700763
- By:
- Publication type:
- Article
6
Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 35, doi. 10.1038/sj.cgt.7700766
- By:
- Publication type:
- Article
7
Growth hormone releasing hormone plasmid supplementation, a potential treatment for cancer cachexia, does not increase tumor growth in nude mice.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 54, doi. 10.1038/sj.cgt.7700767
- By:
- Publication type:
- Article
8
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 61, doi. 10.1038/sj.cgt.7700769
- By:
- Publication type:
- Article
9
CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 84, doi. 10.1038/sj.cgt.7700770
- By:
- Publication type:
- Article
10
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 90, doi. 10.1038/sj.cgt.7700775
- By:
- Publication type:
- Article
11
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 101, doi. 10.1038/sj.cgt.7700779
- By:
- Publication type:
- Article
12
Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 1, p. 72, doi. 10.1038/sj.cgt.7700772
- By:
- Publication type:
- Article